Details of the Probe-central Interaction Altas
General Information of Experiment
| Probe Name | AX-1 | Probe Info | ||||
|---|---|---|---|---|---|---|
| Probe concentration | 1 uM | |||||
| Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
| Quantitative Method |
SILAC
|
|||||
| Competitor Name | 9im | Competitor Info | ||||
| Competitor Concentration | 10 uM | |||||
| In Vivo Experiment Model | Model Type |
|
Living cell | |||
| Derived Tissue |
|
Breast | ||||
| Disease Model | Breast adenocarcinoma [ICD-11:2C60] | |||||
| Model Name | Human breast adenocarcinoma cells (MDA-MB-231) | |||||
Interaction Altas of This Experiment [1]
Enzyme
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP15484 | Saccharopine dehydrogenase-like oxidoreductase (SCCPDH) | 5.1 | ||||
| LDTP02848 | NADPH--cytochrome P450 reductase (POR) | 3.4 | ||||
| LDTP07504 | Lysophospholipid acyltransferase 5 (LPCAT3) | 3.2 | ||||
Transporter and channel
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP03132 | Voltage-dependent anion-selective channel protein 1 (VDAC1) | 4.6 | ||||
| LDTP04071 | Voltage-dependent anion-selective channel protein 2 (VDAC2) | 4.3 | ||||
| LDTP04426 | B-cell receptor-associated protein 31 (BCAP31) | 3.7 | ||||
| LDTP18448 | Transmembrane 9 superfamily member 3 (TM9SF3) | 3.1 | ||||
| LDTP03405 | Calnexin (CANX) | 2.5 | ||||
| LDTP05394 | Caveolin-1 (CAV1) | 2.4 | ||||